Martin Warman

Martin is a Scientific Fellow II at Vertex Pharmaceuticals supporting the use of PAT within a QbD framework, from Development to use in Real Time Release. This includes a special focus on Continuous Processing and Process Innovation. He has over 18 years experience working in the field having previously provided PAT consultancy services to the Pharmaceutical industry as well as leading the PAT Development Team as part of Right First Time in Pfizer Global Manufacturing. Before joining Pfizer he worked for Dionex providing application support for liquid and supercritical fluid chromatography, including on-line measurements. He joined Dionex from Shell Research, where he provided analytical support, developing novel environmental analysis methods and technologies in support of Shell's bio-restoration/bio-remediation projects, and environmental monitoring programs in the North Sea. He has also worked in academia starting his career at the University of Westminster specializing in BioProcessing; and he has a bachelor’s degree in Cell Biochemistry. This provides extensive, cross industry, experience in application identification, solution specification and delivery, as well as the support of systems during product life-cycle and he has experience in a developing and implementing a wide variety of measurement solutions, from spectroscopic, through chromatographic but including acoustic and particle characterisation. Martin is also on the Executive Committee of ASTM E55 covering Pharmaceutical Manufacturing